AIHTA - Publications - Search - Alectinib (Alecensa®) as adjuvant treatment following complete tumour resection for adult patients with ALK‑positive non‑small cell lung cancer (NSCLC)

Rothschedl, E. and Grössmann, N. (2024): Alectinib (Alecensa®) as adjuvant treatment following complete tumour resection for adult patients with ALK‑positive non‑small cell lung cancer (NSCLC). Fact Sheet Nr. 173.

[thumbnail of Fact Sheet Nr.173.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
139kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WF Respiratory system
Language:English
Series Name:Fact Sheet Nr. 173
Deposited on:12 Jun 2024 16:20
Last Modified:12 Jun 2024 16:20

Repository Staff Only: item control page